Advanced Technology Acquisition Corp SPAC Announces Intent to Acquire Medical Device Company Bioness for $247 Million
Advanced Technology Acquisition Corp (Amex: AXC), a $172 million SPAC focused on Israeli acquisitions, announced today that it had entered into a letter of intent to complete a business combination with Bioness, Inc. This announcement adds a six-month extension for completion of a business combination, until June 22, 2009.
Bioness Inc. is a neuromodulation company with significant Israeli operations that makes medical devices and developing implantable products intended to treat various neurological events and conditions (such as stroke and multiple sclerosis), chronic pain and urological syndromes. Bioness’ technologies are used for central nervous system disorders.
